News

FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...
AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...
AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...
Influenza infections are emerging as the primary driver behind the recent surge in viral fever cases across the country, with ...
Parenting guidance isn’t set in stone — it evolves with the science and the times. An expert outlines five practices that ...
Remote-work flexibility has supported workplace equity helped limit outbreaks of respiratory infections. Back-to-offices ...
The risk of infection rises significantly among children during the monsoon. Parents must take special care and precaution to ...
Canadian employers have been mandating workers back to in-person work through blanket return-to-office policies. On top of harming workplace equity ...
Australian shares are set to open lower this morning after US stocks ended roughly flat overnight, as local traders await ...
From that haphazard beginning, the cemetery grew into the final resting place of the Creston Valley’s earliest settlers. In ...
The FDA has approved an at-home nasal spray flu vaccine, and it’s now available for order. FluMist enters the bloodstream ...